DK153440C - Fremgangsmaade til fremstilling af et nasalt farmaceutisk ergotpeptidalkaloid-praeparat - Google Patents

Fremgangsmaade til fremstilling af et nasalt farmaceutisk ergotpeptidalkaloid-praeparat

Info

Publication number: DK153440C
Authority: DK; Denmark
Prior art keywords: ergotpeptidalkaloid; preparing; procedure; preparation; national pharmaceutical
Prior art date: 1976-11-19

Application number

DK499477A

Other languages

English (en)

Other versions

DK153440B (da

DK499477A (da

Inventor

Moise Azria

Thomas Cavanak

Original Assignee

Sandoz Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1976-11-19

Filing date

1977-11-10

Publication date

1989-01-02

1977-11-10 Application filed by Sandoz Ag filed Critical Sandoz Ag

1978-05-20 Publication of DK499477A publication Critical patent/DK499477A/da

1988-07-18 Publication of DK153440B publication Critical patent/DK153440B/da

1989-01-02 Application granted granted Critical

1989-01-02 Publication of DK153440C publication Critical patent/DK153440C/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- G—PHYSICS
- G01—MEASURING; TESTING
- G01D—MEASURING NOT SPECIALLY ADAPTED FOR A SPECIFIC VARIABLE; ARRANGEMENTS FOR MEASURING TWO OR MORE VARIABLES NOT COVERED IN A SINGLE OTHER SUBCLASS; TARIFF METERING APPARATUS; MEASURING OR TESTING NOT OTHERWISE PROVIDED FOR
- G01D2207/00—Indexing scheme relating to details of indicating measuring values
- G01D2207/10—Displays which are primarily used in aircraft or display aircraft-specific information

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Otolaryngology (AREA)
Pulmonology (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

DK499477A 1976-11-19 1977-11-10 Fremgangsmaade til fremstilling af et nasalt farmaceutisk ergotpeptidalkaloid-praeparat DK153440C (da)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
CH1457576		1976-11-19
CH1457576		1976-11-19
CH698977		1977-06-07
CH698977		1977-06-07

Publications (3)

Publication Number	Publication Date
DK499477A DK499477A (da)	1978-05-20
DK153440B DK153440B (da)	1988-07-18
DK153440C true DK153440C (da)	1989-01-02

Family

ID=25700540

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK499477A DK153440C (da)	1976-11-19	1977-11-10	Fremgangsmaade til fremstilling af et nasalt farmaceutisk ergotpeptidalkaloid-praeparat

Country Status (27)

Country	Link
US (2)	US4462983A (da)
JP (1)	JPS5366440A (da)
AT (1)	AT368881B (da)
AU (1)	AU520754B2 (da)
CA (1)	CA1103585A (da)
CS (2)	CS228502B2 (da)
CY (1)	CY1266A (da)
DE (2)	DE2750090A1 (da)
DK (1)	DK153440C (da)
ES (1)	ES464275A1 (da)
FI (1)	FI773376A (da)
FR (1)	FR2371454A1 (da)
GB (1)	GB1592563A (da)
GR (1)	GR65229B (da)
HK (1)	HK85984A (da)
HU (1)	HU185924B (da)
IE (1)	IE46167B1 (da)
IL (1)	IL53419A (da)
KE (1)	KE3453A (da)
MY (1)	MY8400055A (da)
NL (1)	NL187892C (da)
NO (1)	NO773839L (da)
NZ (1)	NZ185711A (da)
PH (1)	PH23643A (da)
PT (1)	PT67292B (da)
SE (1)	SE451944B (da)
SG (1)	SG61784G (da)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2750090A1 (de) *	1976-11-19	1978-06-01	Sandoz Ag	Neue verabreichungsformen fuer organische verbindungen
US4284648A (en) *	1979-08-03	1981-08-18	The University Of Kentucky Research Foundation	Nasal administration of propranolol
CH649300A5 (de) *	1981-08-07	1985-05-15	Sandoz Ag	Ergopeptinderivate, ihre herstellung und verwendung.
FI81258C (fi) *	1982-02-01	1990-10-10	Sandoz Ag	Foerfarande foer framstaellning av en farmaceutisk komposition foer nasal administration.
GB8301659D0 (en) *	1983-01-21	1983-02-23	Leo Ab	Smoking substitutes
GB8413795D0 (en) *	1984-05-30	1984-07-04	Sandoz Ltd	Organic compounds
GB8426922D0 (en) *	1984-10-24	1984-11-28	Sandoz Ltd	Galenic formulation
GB8501015D0 (en) *	1985-01-16	1985-02-20	Riker Laboratories Inc	Drug
FR2628638B1 (fr) *	1985-03-06	1992-12-18	Sandoz Lab	Dispositif de pulverisation par voie nasale d'une dose unitaire de medicament en solution
JPS61263918A (ja) *	1985-05-16	1986-11-21	Banyu Pharmaceut Co Ltd	経皮吸収用製剤
ATE78158T1 (de) *	1985-05-22	1992-08-15	Liposome Technology Inc	Verfahren und system zum einatmen von liposomen.
CA1291036C (en) *	1986-04-23	1991-10-22	Edwin I. Stoltz	Nasal administration of drugs
US4782047A (en) *	1986-05-22	1988-11-01	Syntex Pharmaceuticals International Ltd.	Aqueous steroid formulations for nasal administration
US4897256A (en) *	1986-11-25	1990-01-30	Abbott Laboratories	LHRH analog formulations
DE3710216A1 (de) *	1987-03-27	1988-10-06	Rentschler Arzneimittel	Verwendung von dihydroergotamin und seinen salzen zur lokalen behandlung trophischer stoerungen
DE68915203T2 (de) *	1988-03-22	1994-09-22	Fisons Plc, Ipswich, Suffolk	Pharmazeutische Mischungen.
US4929640A (en) *	1988-04-04	1990-05-29	George D. McAdory	Medicaments intended for combined use in the improvement of lymphocyte function
GB2237510B (en) *	1989-11-04	1993-09-15	Danbiosyst Uk	Small particle drug compositions for nasal administration
IT1247472B (it) *	1991-05-31	1994-12-17	Fidia Spa	Processo per la preparazione di microsfere contenenti componenti biologicamente attivi.
WO1993025193A1 (en) *	1992-06-12	1993-12-23	Teijin Limited	Pharmaceutical preparation for intra-airway administration
ATE222754T1 (de) *	1992-06-12	2002-09-15	Teijin Ltd	Ultrafeines pulver zur inhalation und dessen herstellung
ATE290864T1 (de) *	1993-03-26	2005-04-15	Franciscus Wilhelmus He Merkus	Pharmazeutische zusammensetzungen zur intranasalen verabreichung von dihydroergotamin
US6794357B1 (en) *	1993-06-24	2004-09-21	Astrazeneca Ab	Compositions for inhalation
US6632456B1 (en)	1993-06-24	2003-10-14	Astrazeneca Ab	Compositions for inhalation
US20010003739A1 (en) *	1993-06-24	2001-06-14	Astrazeneca Ab	Systemic administration of a therapeutic preparation
US5830853A (en)	1994-06-23	1998-11-03	Astra Aktiebolag	Systemic administration of a therapeutic preparation
KR100389080B1 (ko) *	1994-12-22	2003-10-17	아스트라제네카 악티에볼라그	부갑상선호르몬(pth)을포함하는흡입용치료제제
PL320856A1 (en)	1994-12-22	1997-11-10	Astra Ab	Aerosol drug preparations
US6524557B1 (en) *	1994-12-22	2003-02-25	Astrazeneca Ab	Aerosol formulations of peptides and proteins
SE9404468D0 (sv) *	1994-12-22	1994-12-22	Astra Ab	Powder formulations
US5955098A (en) *	1996-04-12	1999-09-21	Flemington Pharmaceutical Corp.	Buccal non polar spray or capsule
US7771746B2 (en) *	1999-12-03	2010-08-10	Polichem Sa	Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
JP2003535042A (ja) *	2000-01-20	2003-11-25	バジリアファルマスーチカアーゲー	鼻腔に投与可能な環式ペプチド組成物
US20030008005A1 (en) *	2001-07-05	2003-01-09	R.T. Alamo Ventures, Inc.	Sublingual administration of dihydroergotamine for the treatment of migraine
GB0208742D0 (en) *	2002-04-17	2002-05-29	Bradford Particle Design Ltd	Particulate materials
GB2405334B (en) *	2002-04-17	2006-02-15	Nektar Therapeutics Uk Ltd	Particulate materials
PL2425820T3 (pl)	2007-02-11	2015-08-31	Map Pharmaceuticals Inc	Sposób terapeutycznego stosowania dhe w celu umożliwienia szybkiego złagodzenia migreny przy jednoczesnym zminimalizowaniu profilu działań niepożądanych
US20120000941A1 (en) *	2010-06-30	2012-01-05	Inspire Pharmaceuticals, Inc.	Medicine dispenser
NZ741171A (en)	2015-09-10	2022-01-28	Impel Neuropharma Inc	In-line nasal delivery device
RU2019143750A (ru) *	2017-07-02	2021-08-03	Др. Редди'С Лабораториз Лтд.	Назальные лекарственные формы дигидроэрготамина
US20190209463A1 (en)	2018-01-05	2019-07-11	Impel Neuropharma, Inc.	Intranasal delivery of dihydroergotamine by precision olfactory device
GB2581431A (en) *	2018-12-11	2020-08-19	Satsuma Pharmaceuticals Inc	Compositions, devices, and methods for treating or preventing headaches
CA3122396A1 (en)	2018-12-11	2020-06-18	Satsuma Pharmaceuticals, Inc.	Compositions, devices, and methods for treating or preventing headaches

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1063512A (en) *	1962-11-30	1967-03-30	Benger Lab Ltd	Aerosols
GB1175430A (en) *	1966-04-07	1969-12-23	Sandoz Ltd	Pharmaceutical Compositions containing Ergot Alkaloids
CH507249A (de) *	1968-05-31	1971-05-15	Sandoz Ag	Verfahren zur Herstellung von 2-Brom-a-ergokryptin
CH534683A (de) *	1970-05-26	1973-03-15	Sandoz Ag	Verfahren zur Herstellung neuer Mutterkornpeptidalkaloide
US4076715A (en) *	1972-09-26	1978-02-28	Sandoz Ltd.	13-Bromo lysergic acid compounds
CA990287A (en) *	1972-09-26	1976-06-01	Sandoz Patents Limited	13-bromo-lysergic acid compounds
NL7314066A (da) *	1972-10-18	1974-04-22
US3896228A (en) *	1973-03-15	1975-07-22	Sandoz Ltd	Method for treating nephrises
US3883655A (en) *	1973-10-11	1975-05-13	Sandoz Ltd	Ergocornine or 2-bromo-{60 -ergocyptine in the treatment of parkinsonism
DE2750090A1 (de) *	1976-11-19	1978-06-01	Sandoz Ag	Neue verabreichungsformen fuer organische verbindungen
EP0119493A1 (en) *	1983-03-16	1984-09-26	American Cyanamid Company	Use of copolymers of 2-acrylamido-2-methylpropane sulfonic acid for improving retention and dewatering in the manufacture of paper

1977
- 1977-11-09 DE DE19772750090 patent/DE2750090A1/de not_active Ceased
- 1977-11-10 SE SE7712693A patent/SE451944B/sv not_active IP Right Cessation
- 1977-11-10 FI FI773376A patent/FI773376A/fi not_active Application Discontinuation
- 1977-11-10 DK DK499477A patent/DK153440C/da not_active IP Right Cessation
- 1977-11-10 NO NO77773839A patent/NO773839L/no unknown
- 1977-11-15 CY CY1266A patent/CY1266A/xx unknown
- 1977-11-15 NL NLAANVRAGE7712552,A patent/NL187892C/xx not_active IP Right Cessation
- 1977-11-15 GB GB47437/77A patent/GB1592563A/en not_active Expired
- 1977-11-16 GR GR54819A patent/GR65229B/el unknown
- 1977-11-16 CA CA290,987A patent/CA1103585A/en not_active Expired
- 1977-11-17 NZ NZ185711A patent/NZ185711A/xx unknown
- 1977-11-17 IL IL7753419A patent/IL53419A/xx unknown
- 1977-11-17 FR FR7734591A patent/FR2371454A1/fr active Granted
- 1977-11-17 PT PT67292A patent/PT67292B/pt unknown
- 1977-11-17 HU HU77SA3075A patent/HU185924B/hu unknown
- 1977-11-17 IE IE2345/77A patent/IE46167B1/en not_active IP Right Cessation
- 1977-11-18 ES ES464275A patent/ES464275A1/es not_active Expired
- 1977-11-18 JP JP13803177A patent/JPS5366440A/ja active Granted
- 1977-11-18 CS CS777615A patent/CS228502B2/cs unknown
- 1977-11-18 AT AT0825477A patent/AT368881B/de active
- 1977-11-18 AU AU30783/77A patent/AU520754B2/en not_active Expired
- 1977-11-18 CS CS817502A patent/CS228523B2/cs unknown
1978
- 1978-01-19 DE DE19782802113 patent/DE2802113A1/de not_active Withdrawn
1980
- 1980-08-15 PH PH24447A patent/PH23643A/en unknown
1981
- 1981-12-08 US US06/328,680 patent/US4462983A/en not_active Expired - Lifetime
1984
- 1984-09-01 SG SG617/84A patent/SG61784G/en unknown
- 1984-09-13 KE KE3453A patent/KE3453A/xx unknown
- 1984-11-08 HK HK859/84A patent/HK85984A/xx not_active IP Right Cessation
- 1984-12-30 MY MY55/84A patent/MY8400055A/xx unknown
1986
- 1986-06-09 US US06/871,985 patent/US4758423A/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
FR2371454B1 (da)	1980-08-22
SE7712693L (sv)	1978-05-20
PH23643A (en)	1989-09-27
NL7712552A (nl)	1978-05-23
FI773376A (fi)	1978-05-20
US4462983A (en)	1984-07-31
IE46167L (en)	1978-05-19
DE2750090A1 (de)	1978-06-01
AU520754B2 (en)	1982-02-25
NL187892B (nl)	1991-09-16
GB1592563A (en)	1981-07-08
DK153440B (da)	1988-07-18
NL187892C (nl)	1992-02-17
AT368881B (de)	1982-11-25
ATA825477A (de)	1982-04-15
SG61784G (en)	1985-03-15
IL53419A (en)	1982-04-30
AU3078377A (en)	1979-05-24
ES464275A1 (es)	1978-12-16
IL53419A0 (en)	1978-01-31
SE451944B (sv)	1987-11-09
HU185924B (en)	1985-03-28
PT67292A (fr)	1977-12-01
KE3453A (en)	1984-10-05
JPS6313965B2 (da)	1988-03-29
FR2371454A1 (fr)	1978-06-16
CS228502B2 (en)	1984-04-16
MY8400055A (en)	1984-12-31
PT67292B (fr)	1979-11-12
NO773839L (no)	1978-05-22
DE2802113A1 (de)	1979-07-26
IE46167B1 (en)	1983-03-09
JPS5366440A (en)	1978-06-13
US4758423A (en)	1988-07-19
CY1266A (en)	1984-11-23
CA1103585A (en)	1981-06-23
HK85984A (en)	1984-11-16
GR65229B (en)	1980-07-30
NZ185711A (en)	1980-04-28
DK499477A (da)	1978-05-20
CS228523B2 (en)	1984-05-14

Publication	Publication Date	Title
DK153440C (da)	1989-01-02	Fremgangsmaade til fremstilling af et nasalt farmaceutisk ergotpeptidalkaloid-praeparat
DK271677A (da)	1977-12-22	Fremgangsmade til fremstilling af et farmaceutisk indsetningspreparat
DK584676A (da)	1977-07-03	Fremgangsmade til fremstilling af et stabilt antibiotisk preparat
DK113676A (da)	1976-09-18	Fremgangsmade til fremstilling af et retardpreparat
DK152172C (da)	1988-06-27	Fremgangsmaade til fremstilling af en fast farmaceutisk enhedsdosisform
DK528879A (da)	1980-12-14	Fremgangsmaade til fremstilling af et farmaceutisk praeparat indeholdende isosorbiddinitrat
DK141586C (da)	1980-10-06	Fremgangsmaade til fremstilling af et humleoliepraeparat
DK180277A (da)	1977-10-25	Fremgangsmade til fremstilling af polyprenylderivater
DK157781C (da)	1990-08-13	Fremgangsmaade til fremstilling af et tretinoinholdigt gelpraeparat til lokal applikation
DK334077A (da)	1978-01-23	Fremgangsmade til fremstilling af et polysaccharid
DK525777A (da)	1978-05-30	Fremgangsmaade til fremstilling af en siliciumoxid-latex-blanding
DK203879A (da)	1979-11-19	Fremgangsmaade til fremstilling af en farmaceutisk doseringskomponent
DK148942C (da)	1986-06-30	Fremgangsmaade til fremstilling af et vanduoploeseligt enzympraeparat
DK98076A (da)	1976-09-08	Fremgangsmade til fremstilling af et farmaceutisk preparat
DK7679A (da)	1979-07-18	Fremgangsmaade til fremstilling af et prostaglandinholdigt praeparat
DK523277A (da)	1978-05-27	Fremgangsmaade til fremstilling af et farmaceutisk praeparat med protraheret virkning
DK149192C (da)	1986-08-04	Fremgangsmaade til fremstilling af et stabilt cisplatin-praeparat
DK352578A (da)	1979-02-10	Fremgangsmaade til fremstilling af et farmaceutisk praeparat
DK169378A (da)	1978-10-20	Fremgangsmaade til fremstilling af en oploesning
DK143173C (da)	1981-11-16	Fremgangsmaade til fremstilling af et urinstof-urinstofphosphatholdigt droevtyggerfoder
SE7705851L (sv)	1977-11-22	Forfarande for framstellning av en farmaceutisk komposition
DK159136C (da)	1991-03-11	Fremgangsmaade til fremstilling af et farmaceutisk praeparat til rectal indgivning
DK197477A (da)	1977-11-08	Fremgangsmade til fremstilling af et lipaserigt enzympreparat
DK371477A (da)	1978-02-21	Fremgangsmaade til fremstilling af et praeparat
DK147152C (da)	1984-09-17	Fremgangsmaade til fremstilling af en forblanding til foderbrug

Legal Events

Date	Code	Title	Description
1997-12-15	PUP	Patent expired